Literature DB >> 9120619

Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences.

C L Taylor1, Z Yuan, W R Selman, R A Ratcheson, A A Rimm.   

Abstract

The risk of disability and death and the cost of medical care are particularly high for patients with aneurysmal subarachnoid hemorrhage (SAH) who are 65 years of age or older. A retrospective analysis of 47,408 Medicare patients treated over an 8-year period was performed to determine whether a relationship exists between the mortality rate and surgical volume for older patients with SAH. The mortality rate, length of stay in the hospital, and cost of treatment for patients with SAH in California and New York state were also compared. The mortality rate was 14.3% for patients with SAH who were 65 years old or older and who were treated surgically in hospitals in which an average of five or more craniotomies were performed per year; in hospitals averaging between one and five craniotomies annually the mortality rate was 18.4%; and in those averaging less than one such operation per year the rate was 20.5% (trend p = 0.01). There was no difference in the mortality rate for patients in California versus the rate for those in New York. Surgically and medically treated patients, respectively, left the hospital an average of 6.7 and 5.1 days sooner in California than in New York. The unadjusted average reimbursement from Medicare to hospitals for surgically treated patients averaged $1468 more in New York than in California (p < 0.0001), but was equivalent for medically treated patients in the two states. The mortality rate in older patients who are treated surgically for SAH may be inversely correlated with the annual number of craniotomies performed for SAH in patients 65 years of age or older at a given institution. Hospital stays for patients with SAH are significantly shorter in California than in New York.

Entities:  

Mesh:

Year:  1997        PMID: 9120619     DOI: 10.3171/jns.1997.86.4.0583

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Apolipoprotein E, statins, and risk of intracerebral hemorrhage.

Authors:  Daniel Woo; Ranjan Deka; Guido J Falcone; Matthew L Flaherty; Mary Haverbusch; Sharyl R Martini; Steven M Greenberg; Alison M Ayres; Laura Sauerbeck; Brett M Kissela; Dawn O Kleindorfer; Charles J Moomaw; Christopher D Anderson; Joseph P Broderick; Jonathan Rosand; Carl D Langefeld; Jessica G Woo
Journal:  Stroke       Date:  2013-09-05       Impact factor: 7.914

2.  Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.

Authors:  Daniel Woo; Guido J Falcone; William J Devan; W Mark Brown; Alessandro Biffi; Timothy D Howard; Christopher D Anderson; H Bart Brouwers; Valerie Valant; Thomas W K Battey; Farid Radmanesh; Miriam R Raffeld; Sylvia Baedorf-Kassis; Ranjan Deka; Jessica G Woo; Lisa J Martin; Mary Haverbusch; Charles J Moomaw; Guangyun Sun; Joseph P Broderick; Matthew L Flaherty; Sharyl R Martini; Dawn O Kleindorfer; Brett Kissela; Mary E Comeau; Jeremiasz M Jagiella; Helena Schmidt; Paul Freudenberger; Alexander Pichler; Christian Enzinger; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Jaume Roquer; Peter Kraft; Alison M Ayres; Kristin Schwab; Jacob L McCauley; Joanna Pera; Andrzej Urbanik; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Eva-Maria Stögerer; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Rainer Malik; Martin Dichgans; Steven M Greenberg; Peter M Rothwell; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Carl D Langefeld; Jonathan Rosand
Journal:  Am J Hum Genet       Date:  2014-03-20       Impact factor: 11.025

3.  In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume.

Authors:  Brian L Hoh; James D Rabinov; Johnny C Pryor; Bob S Carter; Fred G Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

4.  Surgical management of intracranial aneurysms in the endovascular era : review article.

Authors:  Alexander M Mason; C Michael Cawley; Daniel L Barrow
Journal:  J Korean Neurosurg Soc       Date:  2009-03-31

5.  Regional variation in acute care length of stay after orthopaedic surgery total joint replacement surgery and hip fracture surgery.

Authors:  John D Fitzgerald; Haoling H Weng; Nelson F Soohoo; Susan L Ettner
Journal:  J Hosp Adm       Date:  2013

6.  Intensive care of aneurysmal subarachnoid hemorrhage: an international survey.

Authors:  Robert D Stevens; Neeraj S Naval; Marek A Mirski; Giuseppe Citerio; Peter J Andrews
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

7.  Similar safety in centers with low and high volumes of endovascular treatments for unruptured intracranial aneurysms: evaluation of the analysis of treatment by endovascular approach of nonruptured aneurysms study.

Authors:  L Pierot; L Spelle; F Vitry
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-21       Impact factor: 3.825

8.  Bigger is bigger. Better is better.

Authors:  Ole Solheim; Johan Cappelen
Journal:  Acta Neurochir (Wien)       Date:  2011-05-04       Impact factor: 2.216

9.  The Impact of Surgical Experience on Major Intraoperative Aneurysm Rupture and Their Consequences on Outcome: A Multivariate Analysis of 538 Microsurgical Clipping Cases.

Authors:  Chung-En Hsu; Tzu-Kang Lin; Ming-Hsueh Lee; Shih-Tseng Lee; Chen-Nen Chang; Chih-Lung Lin; Yung-Hsin Hsu; Yin-Cheng Huang; Tsung-Che Hsieh; Chee-Jen Chang
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

10.  Relationship between annualized case volume and in-hospital motality in subarachnoid hemorrhage: A systematic review and meta-analysis.

Authors:  Jian-Yi Huang; Hong-Yu Lin; Qing-Qing Wei; Xing-Hua Pan; Ning-Chao Liang; Wen Gao; Sheng-Liang Shi
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.